|
1
|
Skinner J, Yankey B and Shelton BK:
Hemophagocytic lymphohistiocytosis. Adv Crit Care. 30:151–164.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Henter JI, Horne A, Aricó M, Egeler RM,
Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski
J and Janka G: HLH-2004: Diagnostic and therapeutic guidelines for
hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer.
48:124–131. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nandhakumar D, Loganatha A, Sivasankaran
M, Sivabalan S and Munirathnam D: Hemophagocytic
lymphohistiocytosis in children. Indian J Pediatr. 87:526–531.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Erker C, Harker-Murray P and Talano JA:
Usual and unusual manifestations of familial hemophagocytic
lymphohistiocytosis and langerhans cell histiocytosis. Pediatr Clin
North Am. 64:91–109. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Allyson Niece M, Zora R..Rogers M,
Naveed-Ahmad M, Anne-Marie-Langevin M and McClain KL:
Hemophagocytic lymphohistiocytosis in Texas: Observations on
ethnicity and race. Pediatr Blood Cancer. 54:424–428.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Allen CE and McClain KL: Pathophysiology
and epidemiology of hemophagocytic lymphohistiocytosis. Hematology
Am Soc Hematol Educ Program. 2015:177–182. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Henter J, Elinder G, Söder O and Ost A:
Incidence in Sweden and clinical features of familial
hemophagocytic lymphohistiocytosis. Acta Paediatr Scand.
80:428–435. 1991.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bergsten E, Horne AC, Aricó M, Astigarraga
I, Egeler RM, Filipovich AH, Ishii E, Janka G, Ladisch S, Lehmberg
K, et al: Confirmed efficacy of etoposide and dexamethasone in HLH
treatment: Long-term results of the cooperative HLH-2004 study.
Blood. 130:2728–2738. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Frimmel S, Hinz M, Schipper J, Bogdanow S,
Mitzner S and Koball S: Cytokine adsorption is a promising tool in
the therapy of hemophagocytic lymphohistiocytosis. Int J Artif
Organs. 42:658–664. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zinter MS and Hermiston ML: Calming the
storm in HLH. Blood. 134:103–104. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Egeler RM, Shapiro R, Loechelt B and
Filipovich A: Characteristic immune abnormalities in hemophagocytic
lymphohistiocytosis. J Pediatr Hematol Oncol. 18:340–345.
1996.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Usmani GN, Woda BA and Newburger PE:
Advances in understanding the pathogenesis of HLH. Br J Haematol.
161:609–622. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Al-Samkari H and Berliner N:
Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 13:27–49.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Aulagnon F, Lapidus N, Canet E, Galicier
L, Boutboul D, Peraldi MN, Reuter D, Bernard R, Schlemmer B,
Azoulay E and Zafrani L: Acute kidney injury in adults with
hemophagocytic lymphohistiocytosis. Am J Kidney Dis. 65:851–859.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Karapinar B, Yilmaz D, Balkan C, Akin M,
Ay Y and Kvakli K: An unusual cause of multiple organ dysfunction
syndrome in the pediatric intensive care unit: Hemophagocytic
lymphohistiocytosis. Pediatr Crit Care Med. 10:285–290.
2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bayer G, Von Tokarski F, Thoreau B,
Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D,
Bernard L, et al: Etiology and outcomes of thrombotic
microangiopathies. Clin J Am Soc Nephrol. 14:557–566.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
George JN and Nester CM: Syndromes of
thrombotic microangiopathy. N Engl J Med. 371:654–666.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Barbour T, Johnson S, Cohney S and Hughes
P: Thrombotic microangiopathy and associated renal disorders.
Nephrol Dial Transplant. 27:2673–2685. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American College
of Medical Genetics and Genomics and the Association for Molecular
Pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kidney Disease: Improving Global Outcomes:
KDIGO Clinical Practice Huideline for Acute Kidney Injury. KDIGO
AKI Guideline. Online Appendices A-F:2012.
|
|
21
|
Dos Santos Mde F, Dos Santos OF, Boim MA,
Razvickas CV, De Moura LA, Ajzen H and Schor N: Nephrotoxicity of
acyclovir and ganciclovir in rats: Evaluation of glomerular
hemodynamics. J Am Soc Nephrol. 8:361–367. 1997.PubMed/NCBI
|
|
22
|
Goodship TH, Cook HT, Fakhouri F, Fervenza
FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering
MC, Rodríguez de Córdoba S, et al: Atypical hemolytic uremic
syndrome and C3 glomerulopathy: Conclusions from a ‘Kidney Disease:
Improving Global Outcomes’ (KDIGO) controversies conference. Kidney
Int. 91:539–551. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sadaat M and Jang S: Hemophagocytic
lymphohistiocytosis with immunotherapy: Brief review and case
report. J Immunother Cancer. 6(49)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Schram AM and Berliner N: How I treat
hemophagocytic lymphohistiocytosis in the adult patient. Blood.
125:2908–2914. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Thaunat O, Delahousse M, Fakhouri F,
Martinez F, Stephan JL, Noël LH and Karras A: Nephrotic syndrome
associated with hemophagocytic syndrome. Kidney Int. 69:1892–1898.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ardalan MR, Shoja MM, Tubbs RS, Esmaili H
and Keyvani H: Postrenal transplant hemophagocytic
lymphohistiocytosis and thrombotic microangiopathy associated with
parvovirus B19 infection. Am J Transplant. 8:1340–1344.
2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chiang WC, Wu MS, Tsai CC, Lin SL, Tsai TJ
and Hsieh BS: Thrombotic microangiopathy in hemophagocytic
syndrome: A case report. J Formos Med Assoc. 101:362–367.
2002.PubMed/NCBI
|
|
28
|
XX Chu, Zhang Y and Liao SJ: A case of HLH
complicated with renal damage of thrombotic microangiopathy. Chin J
Nephrol. 33:625–626. 2017.
|
|
29
|
Haytoglu Z, Yazici N and Erbay A:
Secondary hemophagocytic lymphohistiocytosis: Do we really need
chemotherapeutics for all patients? J Pediatr Hematol Oncol.
39(e106-e109)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bae MN, Kwak DH, Park SJ, Choi BS, Park
CW, Choi YJ, Lee JW, Yang CW, Kim YS and Chung BH: Acute kidney
injury induced by thrombotic microangiopathy in a patient with
hemophagocytic lymphohistiocytosis. BMC Nephrol.
17(4)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Esmaili H, Mostafidi E, Mehramuz B,
Ardalan M and Mohajel-Shoja M: An update on renal involvement in
hemophagocytic syndrome (macrophage activation syndrome). J
Nephropathol. 5:8–14. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Inagaki N, Sugimoto K, Hosone M, Isobe Y,
Yamamoto Y, Sasaki M, Kato A, Mori T and Oshimi K: Disseminated
Mucor infection and thrombotic microangiopathy in
lymphoma-associated hemophagocytic syndrome. Int J Hematol.
88:355–356. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ardalan MR: Review of thrombotic
microangiopathy (TMA), and post-renal transplant TMA. Saudi J
Kidney Dis Transpl. 17:235–244. 2006.PubMed/NCBI
|
|
34
|
Ishiguro T, Kojima A, Shimizu T, Mita N,
Kuroiwa S and Takayanagi N: Combined hemophagocytic syndrome and
thrombotic microangiopathy due to mixed infection with influenza
virus and pneumococcal pneumonia. Clin Case Rep. 7:131–134.
2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yu XJ, Yu F, Song D, Wang SX, Song Y, Liu
G and Zhao MH: Clinical and renal biopsy findings predicting
outcome in renal thrombotic microangiopathy: A large cohort study
from a single institute in China. ScientificWorldJournal.
2014(680502)2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Goldberg RJ, Nakagawa T, Johnson RJ and
Thurman JM: The role of endothelial cell injury in thrombotic
microangiopathy. Am J Kidney Dis. 56:1168–1174. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Canna SW and Marsh RA: Pediatric
hemophagocytic lymphohistiocytosis. Blood. 135:1332–1343.
2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mărginean MO, Molnar E and Chinceşan MI:
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in
a small child: A case report. Medicine (Baltimore).
99(e18759)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Munoz J, Shareef N and Donthireddy V:
Cytomegalovirus-induced haemophagocytic lymphohistiocytosis
syndrome. BMJ Case Rep. 2012(bcr1020114963)2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Esteban YM, de Jong JLO and Tesher MS: An
overview of hemophagocytic lymphohistiocytosis. Pediatr Ann.
46:e309-e313:2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Meeths M, Horne A, Sabel M, Bryceson YT
and Henter JI: Incidence and clinical presentation of primary
hemophagocytic lymphohistiocytosis in Sweden. Pediatr Blood Cancer.
62:346–352. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Risma KA and Marsh RA: Hemophagocytic
lymphohistiocytosis: Clinical presentations and diagnosis. J
Allergy Clin Immunol Pract. 7:824–832. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Locatelli F, Jordan MB, Allen C, Cesaro S,
Rizzari C, Rao A, Degar B, Garrington TP, Sevilla J, Putti MC, et
al: Emapalumab in children with primary hemophagocytic
lymphohistiocytosis. N Engl J Med. 382:1811–1822. 2020.PubMed/NCBI View Article : Google Scholar
|
